TempraMed Receives First Commercial Order from Israel Distributor and Completes Initial Shipment Enabling Entry into National Pharmacy Network #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Technology #CSEStocks #SmallCaps #Investing
Vancouver, British Columbia--(Newsfile Corp. - January 6, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce its first commercial order in Israel and the successful delivery of an initial shipment to the warehouse of Guri A.A.O. ("Guri"), a leading Israeli medical distribution company.Guri is among the top five distributors in...
http://dlvr.it/TQBvwL
http://dlvr.it/TQBvwL
Comments
Post a Comment